Testing effectiveness (Phase 2)UnknownNCT02752243
What this trial is testing
CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.
Who this might be right for
Myelodysplastic SyndromesAcute Leukemia
Peter Bader 32